# US 9,044,527 B2 · Wound care products with peracid compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 9,044,527 B2
- Document ID: US9044527B2
- Status: Granted
- Kind: B2
- Application number: 13/967,080
- Filed: 2013-08-14
- Published: 2013-12-12
- Granted: 2015-06-02
- Earliest claimed: 2011-02-17
- Assignees: CHD Bioscience, Inc.
- Applicants: CHD Bioscience, Inc.
- Inventors: Edwin D. Neas; Michael K. Handley; Kevin S. Marchitto; Stephen T. Flock
- Web page: https://patentgrep.com/patent/US9044527B2

## CPC

- A61K 31/327: Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
- A01N 37/42: containing within the same carbon skeleton a carboxylic group or a thio analogue, or a derivative thereof, and a carbon atom having only two bonds to hetero atoms with at the most one bond to halogen, e.g. keto-carboxylic acids
- A01N 59/00: Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A61F 13/0243: {characterised by the properties of the skin contacting layer, e.g. air-vapor permeability}
- A61F 13/0246: characterised by the skin-adhering layer
- A61K 9/7007: {Drug-containing films, membranes or sheets (A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence)}
- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 31/22: of acyclic acids, e.g. pravastatin
- A61K 33/40: Peroxides
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K 47/32: Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone}
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61L 26/0066: {Medicaments; Biocides}
- C08J 5/18: Manufacture of films or sheets
- C08J 2329/04: Polyvinyl alcohol; Partially hydrolysed homopolymers or copolymers of esters of unsaturated alcohols with saturated carboxylic acids
- C08J 2375/04: Polyurethanes
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)

## Abstract

Methods have been developed for incorporation of a peracid compound into or on wound application matrices, such as bandages or dressings, and other matrices which will favorably impact wound healing and help eliminate microbial infection. The peracid compound comprises a base compound that is metabolically pertinent to wound healing, the oxidized form of the base compound (a peracid), and an appropriate oxidizer, such as hydrogen peroxide. In addition, other excipients with wound healing potential, such as esters of the base compound, may be added to the peracid compound. The combination peracid-wound application matrices can be used to disinfect and heal various wound types with designed time release of the peracid compound.

## Claims

### Claim 1

A wound treating matrix comprising at least one layer which is non-aqueous that comprises an antimicrobial composition comprising a carboxylic acid, the peracid of said carboxylic acid, the ester of said carboxylic acid, and an oxidizer in a non-aqueous medium.

### Claim 2 (depends on 1)

The wound treating matrix according to claim 1, wherein the non-aqueous layer is biodegradable.

### Claim 3 (depends on 1)

The wound treating matrix according to claim 1, wherein the non-aqueous layer is dissolvable.

### Claim 4 (depends on 1)

The wound treating matrix according to claim 1, further comprises:
an aqueous layer;
wherein the aqueous layer is separated from the non-aqueous layer prior to use;
wherein in use, the non-aqueous layer is exposed to the aqueous layer, and the antimicrobial composition migrates into the aqueous layer.

### Claim 5 (depends on 4)

The wound treating matrix according to claim 4, further comprising a removable fluid-resistant barrier layer for initially separating the non-aqueous layer from the aqueous layer, wherein in use, the barrier is removed to allow contact between the non-aqueous layer and the aqueous layer.

### Claim 6 (depends on 1)

The wound treating matrix according to claim 1, wherein the antimicrobial composition is released from the non-aqueous layer when contacted with a water based fluid.

### Claim 7 (depends on 6)

The wound treating matrix according to claim 6, wherein the water based fluid is wound exudate.

### Claim 8 (depends on 1)

The wound treating matrix according to claim 1, wherein the non-aqueous layer provides a controlled release of the antimicrobial composition when contacted with a water based fluid.

### Claim 9 (depends on 4)

The wound treating matrix according to claim 4, wherein the aqueous layer provides a controlled delivery of the antimicrobial composition when contacted with a water based fluid or exudate.

### Claim 10 (depends on 4)

The wound treating matrix according to claim 4, wherein the aqueous layer is a hydrogel.

### Claim 11 (depends on 1)

The wound treating matrix according to claim 1, further comprising a surfactant.

### Claim 12 (depends on 1)

The wound treating matrix according to claim 1, further comprising a stabilizing agent.

### Claim 13 (depends on 1)

The wound treating matrix according to claim 1, further comprising an emulsifying agent.

### Claim 14 (depends on 1)

The wound treating matrix according to claim 1, wherein the peracid is a peroxy α-ketocarboxylic acid.

### Claim 15 (depends on 14)

The wound treating matrix according to claim 14, wherein the peroxy α-ketocarboxylic acid is selected from peroxy α-ketopyruvic acid, peroxy α-ketobutyric acid, peroxy α-ketovaleric acid, or a mixture of thereof.

### Claim 16 (depends on 1)

The wound treating matrix according to claim 1, further comprising a liquid-impermeable backing layer adjacent to the non-aqueous layer.

### Claim 17 (depends on 16)

The wound treating matrix according to claim 16, wherein the backing layer is adhesive-coated and provides an adhesive-coated margin around the non-aqueous layer.

### Claim 18 (depends on 1)

The wound treating matrix according to claim 1, wherein the non-aqueous layer further comprises a polymer and the peracid is chemically bonded to the polymer.

### Claim 19 (depends on 1)

A method for treating a wound, comprising providing the wound treating matrix according to claim 1, and topically applying the wound treating matrix to the wound.

### Claim 20 (depends on 1)

A wound treating matrix according to claim 1 further comprising at least one layer comprising a wound treating agent.

### Claim 21 (depends on 20)

The wound treating matrix according to claim 20, wherein the wound treating agent is one or more of (1) hemostatic agent, (2) anti-inflammatory drug, (3) analgesic drug, (4) angiogenesis promoters.

### Claim 22 (depends on 1)

A wound treating matrix comprising a wound treating agent and a peracid composition according to claim 1, wherein the peracid composition is encapsulated in a biocompatible structure.

### Claim 23 (depends on 22)

The wound treating matrix of according to claim 22, wherein the biocompatible structure is a nanostructure, liposome, or micelle.

### Claim 24 (depends on 1)

A wound treating matrix according to claim 1 further comprising a polymer and wherein the peracid is chemically bonded to the polymer.

### Claim 25 (depends on 24)

The wound treating matrix according to claim 24, wherein the polymer is polyvinyl.

### Claim 26 (depends on 24)

The wound treating matrix according to claim 24, wherein the polymer is polyurethane.

### Claim 27 (depends on 24)

The wound treating matrix according to claim 24, wherein the polymer is a resin or protein.
